日本患有失眠症患者的达里多雷克桑:一个第三阶段,随机,双盲,安慰剂控制的研究
Naohisa Uchimura1, Mitsutaka Taniguchi2, Yu Ariyoshi3
1Kurume University, Kurume, Fukuoka, Japan.
Sleep medicine
|August 8, 2024
概括
达里多雷克桑特有效地改善了日本成年人失眠障碍的睡眠,增加了总睡眠时间,减少了睡眠开始的延迟时间. 药物耐受性很好,第二天早上没有嗜睡或戒断症状.
科学领域:
- 睡眠医学 睡眠医学
- 临床药理学 临床药理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 失眠症严重影响患者的生活质量和医疗费用.
- 素受体对抗剂代表了治疗失眠的新疗法.
- 在不同人群中评估新的失眠治疗方法至关重要.
研究的目的:
- 评估在患有失眠障碍的日本患者中达里多雷克桑的疗效和安全性.
- 为了确定这个人群中达里多雷克桑的最佳剂量.
- 评估潜在的第二天早上的残留效应和戒断症状.
主要方法:
- 第三阶段,双盲,安慰剂对照研究.
- 490名日本患者随机分配给达里多雷克桑 (25或50毫克) 或安慰剂4周.
- 主要终点:主观总睡眠时间 (sTST) 和睡眠开始延迟 (sLSO) 的变化.
主要成果:
- 达里多雷克桑50毫克显著改善了sTST和sLSO与安慰剂相比 (p < 0.001).
- 达里多雷克桑25毫克也显示了sTST (p = 0.042) 和sLSO (p = 0.006) 的显著改善.
- 各组的不良反应相似;随着剂量增加,睡眠感增加,但没有影响第二天早上的警觉性.
结论:
- 达里多雷克桑 (25和50毫克) 是有效的,并且在日本患者治疗失眠障碍时耐受良好.
- 该药物显著改善了关键的主观睡眠参数.
- 没有观察到任何残留效应或戒断症状,这表明了有利的安全性.
相关概念视频
Management of Insomnia
237
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
237
Sedatives and Hypnotics Drugs: Miscellaneous Agents
163
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
163
Substance Use Disorders Affecting Sleep
163
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
163
REM Sleep Behavior Disorder
167
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
RBD is significantly associated with...
167
Antidepressant Drugs: MAOIs and Other Agents
209
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
209
Anxiolytic Drugs: Overview
248
Anxiolytic drugs are vital in managing anxiety disorders by effectively alleviating symptoms such as excessive fear, tachycardia, and tremors. There are several classes of anxiolytic medications, each with unique mechanisms of action and potential side effects.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
248


